Announce Date | 05/15/2025 |
EPS Normalized Actual | $0.2 (Beat by $0.11) |
EPS GAAP Actual | $0.2 (Beat by $0.11) |
Revenue Actual | $0.164226B |
Revenue Surprise | Beat by $164.226M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.07 |
EPS GAAP Estimate | $0.07 |
Revenue Estimate | $0.1851B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2026 | 0.33 | 14.64 | 0.32306 | 0.34379 | 1 |
Dec 2025 | 0.53 | 9.11 | 0.51288 | 0.57604 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.2 | 0.36 | 0.164226B | 15.64% | 15.03M |
FQ4 2024 (Dec 2024) | -0.32 | -0.323333 | 0.136827B | -8.46% | -0.14M |
FQ3 2024 (Sep 2024) | 0.22 | 0.14 | 0.135271B | -32.68% | -28.3M |
FQ2 2024 (Jun 2024) | 0 | -0.03 | 0.163066B | 100% | -3.17M |
FQ4 2021 (Nov 2021) | -0.0003 | -0.0003 | 0B | NAN% | 0M |
FQ1 2022 (Mar 2022) | -0.0111 | -0.0111 | 0B | NAN% | 0M |
FQ1 2024 (Mar 2024) | -0.0926 | -0.0226 | 0.138539B | -18.09% | -25.58M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0.148406B | -0.85% | -75.95M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0.07
Consensus Revenue Estimates
0.1851B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 0.11 | -- | 0.10914 | 0.11105 | 1 |
FQ2 2026 (Jun 2026) | 0.16 | -- | 0.15875 | 0.16153 | 1 |
FQ1 2026 (Mar 2026) | 0.15 | -33.33 | 0.14883 | 0.15143 | 1 |
FQ4 2025 (Dec 2025) | -0.03 | -966.67 | -0.03386714 | -0.02613286 | 2 |
FQ3 2025 (Sep 2025) | 0.07 | -214.29 | 0.07 | 0.07 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 0.17B | -- | 0.17B | 0.17B | 2 |
FQ2 2026 (Jun 2026) | 0.18B | -- | 0.18B | 0.18B | 2 |
FQ1 2026 (Mar 2026) | 0.17B | 5.28 | 0.17B | 0.17B | 3 |
FQ4 2025 (Dec 2025) | 0.15B | 9.21 | 0.14B | 0.17B | 0 |
FQ3 2025 (Sep 2025) | 0.19B | 26.92 | 0.19B | 0.19B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
5
EPS # of in-lines
1
Revenue # of Beats
1
Revenue # of Misses
5
Revenue # of in-lines
2
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.16 | 0.2 | 0.36 | 180% |
FQ4 2024 (Dec 2024) | 0.003333 | -0.32 | -0.323333 | 101.04% |
FQ3 2024 (Sep 2024) | 0.08 | 0.22 | 0.14 | 63.64% |
FQ2 2024 (Jun 2024) | 0.03 | 0 | -0.03 | -INF% |
FQ4 2021 (Nov 2021) | -0.0003 | -0.0003 | 100% | |
FQ1 2022 (Mar 2022) | -0.0111 | -0.0111 | 100% | |
FQ1 2024 (Mar 2024) | -0.07 | -0.0926 | -0.0226 | 24.41% |
FQ4 2023 (Dec 2023) | 0 | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.15B | $0.16B | $15.03M | 9.15% |
FQ4 2024 (Dec 2024) | $0.14B | $0.14B | $-0.14M | -0.1% |
FQ3 2024 (Sep 2024) | $0.16B | $0.14B | $-28.3M | -20.92% |
FQ2 2024 (Jun 2024) | $0.17B | $0.16B | $-3.17M | -1.95% |
FQ4 2021 (Nov 2021) | $0B | $0B | $0M | NAN% |
FQ1 2022 (Mar 2022) | $0B | $0B | $0M | NAN% |
FQ1 2024 (Mar 2024) | $0.16B | $0.14B | $-25.58M | -18.46% |
FQ4 2023 (Dec 2023) | $0.22B | $0.15B | $-75.95M | -51.18% |